Dr. Sulaiman Al-habib Medical Services Group Co. · TADAWUL:4013
Dr. Sulaiman Al-habib Medical Services — FY2021 Earnings Presentation
37 slides from Dr. Sulaiman Al-habib Medical Services's earnings presentation, Feb 24, 2022
Slide 1: FY 2021 Earnings Call Presentation
FY 2021 Earnings Call Presentation Thursday, 24 February 2022 16:00 (Saudi), 17:00 (UAE), 14:00 (UK), 09:00 (New York)
Slide 2: Disclaimer
Disclaimer Disclaimer and important information in relation to this presentation This presentation has been prepared solely for use as earnings presentation of Dr. Sulaiman Al Habib Medical Services Group Company (the “Company”). By attending or by reading this presentation, you agree to be bound by
Slide 3: Presenting team
Presenting team Faisal Al Nassar Ziyad Al Dahami Chief Financial Officer Head of Investor Relations FY 2021 Earnings Call Presentation 3 February 2022
Slide 4: Agenda
AGENDA Growth Strategy How we performed Spotlight Technology and medical excellence Appendix #1 About HMG Appendix #2 Summarized financials FY 2021 Earnings Call Presentation 4 February 2022
Slide 5: Growth Strategy
medical group auhilacg.02.0/) qe > oO < = I < E 22 EF > a ia a
Slide 6: Equity story and strategy
Equity story and strategy A well-defined strategy enhanced by our core values Vision Mission To be the most trusted healthcare provider in medical excellence and To develop and operate state of the art medical facilities and provide patient experience globally innovative healthcare services to creat
Slide 7: Key messages
Key messages A best-in-class healthcare leader with a clear growth strategy Best-in-class Catalysts for value creation Efficiency drivers • Regional integrated healthcare provider with • Technology: Pioneer in healthcare technology, • Efficient cash conversion cycle: shortest 25+ years track record
Slide 8: HMG is contributing to the goals of Vision 2030
HMG is contributing to the goals of Vision 2030 Commissioning Primary Long term of hospital care care Rehabilitation services and medical cities Areas of focus for privatization Home care Pharmacy Laboratory services Radiology How has HMG positioned itself to participate? Intensive Care Units (ICUs)
Slide 9: Business structure
Business structure A fully integrated healthcare services provider Hospitals Pharmacies HMG Solutions 7 hospitals (22+ medical facilities) Outpatient pharmacies as part of the Cloud Solutions: technology arm in Saudi Arabia and Dubai hospitals including HIS, e-medicine, mobile app & other Appl
Slide 10: Where we operate
Where we operate With total built-up area of 689,000+ m2, HMG owns most of its hospital properties Tabuk Olaya Medical NEOM Qatif Opened 1995 (OPD) Opened 2010 Complex Rayan Bahrain Dammam Beds 349 Beds 260 Qassim Khobar Madinah Dubai BUA 144,287 m2 BUA 69,098 m2 Riyadh Takhassusi Opened 2012 Opened
Slide 11: How we performed
Gu.I5!luLor =) DR SULAIMAN AL HABIB Xx nedical group auiniargoa. How we performed
Slide 12: Projects update
Projects update Solidifying our market leadership through a robust expansion plan North Riyadh Hospital 100% SAR 659.5 mn SAR 2.2 bn Ownership Land Construction 2023 500 Expected Beds Land Design MOH License Excavation Construction South-West Jeddah Hospital 50% SAR 132.6 mn SAR 1.5 bn Ownership Lan
Slide 13: Projects update
Projects update Solidifying our market leadership through a robust expansion plan Maternity and Pediatric Hospital (New Takhassusi Expansion) 100% SAR 80.8 mn SAR 391 mn Ownership Land Construction 2024 145 Expected Beds Land Design Initial MOH Excavation Construction License North Jeddah Hospital 1
Slide 14: Projects update
Projects update Solidifying our market leadership through a robust expansion plan Sehat Al Kharj Hospital 100% SAR 30.2 mn SAR 455 mn Ownership Land Construction 2024 141 Expected Beds Land Design Initial MoH Excavation Construction license Medical Center Services Newly announced projects Expansion
Slide 15: Highlights: FY 2021
Highlights: FY 2021 Committed to the well-being of the communities we serve and to value creation by looking beyond our own facilities ESG & Sustainability CSR Activities HMG held several conferences in major medical topics to HMG is currently undertaking a four-phase exercise to start integrating
Slide 16: Highlights: FY 2021 Medical Excellence
Highlights: FY 2021 Medical Excellence Post-Graduate Responsible for all symposia, Deliver optimum training activities CME workshops, courses & conferences Program 17 Residency & 120+ 265+ enrolled across 5 230+ 500+ 12,200+ 500+ Fellowship programs Participant SCHS- accredited diploma accredited by
Slide 17: Attracting and retaining top talent
Attracting and retaining top talent Our employees are our most valuable assets Physician Qualifications Our People 35% Saudization across the Group 3,000+ physicians 43% 37% 20% Staff Ratio Other Western Saudi 63% female : 37% male (including North America 15+ years average & UK) years of experience
Slide 18: Highlights: FY 2021 Operations
Highlights: FY 2021 Operations Recognitions and Accreditations Launch of NABAD 24 (tele-cardiology) program to treat heart attacks HMG continues to receive awards and accreditations from organizations around remotely, the world each year in recognition of our service quality and standards. The Group
Slide 19: Highlights: 2021 Patient overview
Highlights: 2021 Patient overview Patient overview Revenue by type 63.0% 4.4m+ 58.7% 2020 2021 29.5% 29.0% Patients served From 3.2m in 2020 9.7% 6.0% 2.1% 2.0% Insurance Cash Government Others Bed occupancy - overall Bed occupancy - ICU 72.1% 80% FY 2021 Earnings Call Presentation 19 February 2022
Slide 20: Financial highlights: FY 2021
Financial highlights: FY 2021 Revenue by segment SAR million +23.69% Gross profit 24.99% Gross profit Margin FY 2021 2,330.23 FY 2021 32.14% FY 2020 FY 2021 FY 2020 1,864.41 FY 2020 31.81% SAR (Millions) 258.78 308.48 4.41% 4.25% 1,000.51 1,355.99 17.07% 18.70% EBITDA 23.74% EBITDA margin 5,861.60 7
Slide 21: Healthy balance sheet / FY 2021
Healthy balance sheet / FY 2021 FY 2020 FY 2021 Total assets Total assets SAR 9.48 billion SAR 10.83 billion ROE ROA FY 2021 26.86 % FY 2021 13.56 % Cash, time Current deposit & bank 17.86% 18.91% FY 2020 22.69 % FY 2020 11.76 % 24.67% 24.42% liabilities balances Accounts receivable 8.31% Non- ROCE
Slide 22: Low leverage levels / FY 2021
Low leverage levels / FY 2021 Total liabilities and equity SAR million 120.00% Total Liabilities/Total Assets Total Liabilities/Equity 100.00% FY 2021 0.5x FY 2021 1.0x FY 2020 0.5x FY 2020 0.86x 80.00% 5,088.53 53.67% 51.05% 5,527.08 60.00% Net Debt / EBITDA Net Debt / Equity FY 2021 0.2x FY 2021 0
Slide 23: Total cash dividends for shareholders: Q4 2021
Total cash dividends for shareholders: Q4 2021 Declared dividends Declared Cash dividends / Q4 2021 Total distributed dividends SAR 245 million 0.70 0.70 0.70 0.70 % of capital 7% (equivalent to SAR 0.70 per share) 0.60 0.60 245 245 245 245 The eligibility of dividends shall be for those who own the
Slide 24: Vote for us
Best Investor Relations Program Award- Voting Now Open Vote for us Best Investor Relations Program Saudi Capital Market Awards To participate in the survey click here Voting closes 28 February 2022 FY 2021 Earnings Call Presentation 24 February 2022
Slide 25: Q&A
Q&A FY 2021 Earnings Call Presentation 25 February 2022
Slide 26: Spotlight: Technology and medical excellence
Spotlight Technology and medical excellence
Slide 27: Developing cutting edge technology
Developing cutting edge technology Pioneer in award-winning hospital information system and applications in the MENA region Cloud Solutions’ footprint 15+ Years of experience in deploying technology solutions in healthcare domain 15 Products 50+ Digital hospitals R&D- Jordan 15+ Clients Regional off
Slide 28: Pioneer in healthcare technology
Pioneer in healthcare technology Better medical outcomes, exceptional patient experience, and advanced operational practices Tele-medicine HIS (VIDA) Mobile application Medical record anywhere anytime Tele-Cardiology (Nabad 24 program) First-of-its-kind electronic portal Patients • Designed to tre
Slide 29: Pioneer in healthcare technology
Pioneer in healthcare technology Adapting services to meet patient needs Knee replacement technology Siemens Healthineers partnership CSSD MICS Program Innovative minimally invasive Nuclear service center expanded Centralized Sterilization Supply Minimally invasive cardiac surgery knee replacement o
Slide 30: Appendix #1: About HMG
Appendix #1 About HMG
Slide 31: Diverse board of directors
Diverse board of directors Our success is driven by our people 2 Non-Executives 3 Executives 4 Independents Dr. Sulaiman Al Habib Nasser Al Huqbani Mazen Al Rumaih Board Member and CEO Vice Chairman Chairman • Member, Saudi Patient Safety • Chairman, Saudi Fransi Bank • Founder of HMG Center (SPSC)
Slide 32: Experienced senior management
Experienced senior management Highly experienced, high caliber management Nasser Al Huqbani Chief Executive Officer Core functions Corporate functions Hesham Al Habib Saud Al Arifi Abdulwahab Faisal Al Nassar Vice President, Vice President, General Al Abdulwahab Chief Financial Officer Business Deve
Slide 33: Appendix #2: Summarized financials
Appendix #2 Summarized financials
Slide 34: Summary: Balance sheet
Summary: Balance sheet As of 31 December 2021 SAR million As of 31 December 2021 As of 31 December 2020 Current Assets 4,133.43 3,793.36 Investment in subsidiaries & Associates 41.36 39.87 Property and Equipment 6,652.58 5,647.94 Total Assets 10,827.37 9,481.17 Current Liabilities 2,047.72 1,693.73
Slide 35: Summary: Income statement
Summary: Income statement As of 31 December 2021 SAR million 31 December 2021 31 December 2020 Change % Revenue 7,250.47 5,861.60 23.69% Cost of revenue (4,920.24) (3,997.19) 23.09% Gross profit 2,330.23 1,864.41 24.98% Selling and marketing expenses (242.33) (214.67) 12.88% G&A expenses (621.75) (5
Slide 36: Summary: Cash flow statement
Summary: Cash flow statement As of 31 December 2021 SAR million 31 December 2021 31 December 2020 Net cash from operating activities 2,182.79 2,234.29 Net cash used in investing activities (1,247.52) (811.98) Net cash from (used in) financing activities (630.70) (279.71) Cash and cash equivalents at
Slide 37: Dr. Sulaiman Al Habib Medical Services Group contact details
Dr. Sulaiman Al Habib Medical Services Group Tel: +966 11 525 9999 Ext# 4919 Fax: +966 11 217 4980 Mob: +966 50 338 2785 Email: investor.relations@drsulaimanalhabib.com P.O. Box 301578 Riyadh 11372, Kingdom of Saudi Arabia www.hmg.com FY 2021 Earnings Call Presentation 37 February 2022
Dr. Sulaiman Al Habib Medical Services Group — FY2021 Earnings Presentation on 6ix